Waaree’s Hydrogen Bet

Waaree Energies’ push into green hydrogen looks like a positive long-term move for shareholders, but the near-term value depends on execution, capital discipline, and how fast these projects turn into steady earnings. The company is moving from plans to real contracts, which is usually better than staying in headline stage only. The biggest takeaway for investors is that Waaree is trying to build a recurring-revenue business alongside its core solar manufacturing. Its subsidiary, Waaree Clean Energy Solutions, signed a 15-year EAAS deal with Zero Footprint Industries for a 2.5 MW alkaline electrolyser, and also has an MoU to supply up to 50 MW of electrolysers for decentralized projects in North India. The 2.5 MW system is expected to produce about 41 lakh Nm3 of green hydrogen and 20 lakh Nm3 of green oxygen every year. From a shareholder angle, this is beneficial because it can reduce dependence on one-off solar module sales and add more predictable cash flows over time. Waaree’s broader green-energy expansion is also supported by strong operating scale, with market commentary placing revenue around Rs 26,536.8 crore and PAT around Rs 3,884.2 crore, while the company has also guided for operating EBITDA of Rs 7,000-7,700 crore for FY27. There are, however, meaningful risks. Green hydrogen is still an early-stage industry, so project delays, technology issues, policy shifts, and heavy upfront spending can hurt returns. If capital is deployed too aggressively before demand and margins mature, shareholders may see earnings pressure before the benefits arrive. For a company like Waaree, this move is best seen as a strategic option value play rather than an immediate profit driver. If execution stays strong, the hydrogen push can improve long-term growth visibility and valuation support. If not, it could become a costly diversification experiment.